Dr. Mandell’s research program is focused on discovering and validating biomarkers of synaptic degeneration, using a global proteomics screening platform. Other research in the laboratory seeks to identify novel biomarkers of inflammatory myopathies, especially inclusion body myositis, focusing on noncoding RNAs that can be detected both in muscle biopsies as well as in the circulation.